The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
about
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementThe feasibility of lung transplantation in HIV-seropositive patientsThe complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.HIV-associated obstructive lung diseases: insights and implications for the clinician.Infections in "noninfectious" lung diseases.COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated.Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection.A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia.Maintaining lung health with longstanding HIV.Non-infectious Pulmonary Diseases and HIV.HIV-related pneumococcal disease prevention in adults.Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.Community-Acquired Pneumonia in HIV-Infected Individuals.Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patientsThe changing landscape of HIV-related lung disease: non-AIDS lung malignancy as a player in the fieldPulmonary disease in HIV-infected adults in the era of antiretroviral therapy.
P2860
Q26799659-84402A1E-1FD8-4617-B846-52B199F99832Q28242762-97F48B78-0DC9-4932-A607-045A0E8F11B5Q33705883-EB8E0373-1573-412C-B98D-79D10631F543Q33950594-4052696B-20B8-45E4-B209-C26E844789BFQ34357445-9EABB4CD-F50D-4939-82F0-4EDCB50707D0Q36240320-9C6BB973-A776-483E-ADC8-04D462D1E568Q36871006-DC541824-E1F4-49C8-8B86-68D59AE12573Q37080373-F6EB0AB2-6009-49F0-90A2-BDF054D9FA34Q37713483-C1052C5D-AE5D-43F9-936C-74F22D476A53Q38629654-A9FE63AF-2D17-41F4-A812-2ECA7528C268Q38819315-9C44CFE5-4E16-45E0-BC66-3EE1BC2AEF8BQ38947827-DC0A67B6-398B-4DF2-8C49-D1C638C6382BQ39037971-338400F4-7046-4EF1-A345-4CE6F3DA6996Q42235608-47F16C9E-FE19-4481-A8E3-A169A62075B3Q42724109-2D89BF5B-5844-452B-B841-4ED9B44CE556Q42758641-5EC1CE81-8CD2-4F1B-AAB3-C4E02B0BE136Q47693953-BAF0CCEA-8CA8-4FA4-8C5B-BEEB081BB715
P2860
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@ast
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@en
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@nl
type
label
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@ast
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@en
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@nl
prefLabel
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@ast
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@en
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@nl
P2093
P2860
P50
P1433
P1476
The impact of HAART on the res ...... in the MACS and WIHS cohorts.
@en
P2093
Alison Morris
Charles R Rinaldo
Christine B Alden
Eric C Kleerup
Eric C Seaberg
G K Balasubramani
John Phair
Laurence Huang
Matthew R Gingo
Nancy A Hessol
P2860
P304
P356
10.1371/JOURNAL.PONE.0058812
P407
P577
2013-03-12T00:00:00Z